Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 46-52

  Witkin, Jeffrey M ^a   Steele, Thomas D ^a,b   Sharpe, Lawrence G ^a  

^a NIDA Addiction Research Center   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; 2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; 3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 5,7 DICHLOROKYNURENIC ACID; 7 CHLOROKYNURENIC ACID; CYCLOSERINE; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; GLYCINE; GLYCINE RECEPTOR; GLYCINE RECEPTOR AGONIST; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; STRYCHNINE;

ANIMAL EXPERIMENT; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG EFFECT; DRUG SCREENING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DISCRIMINATION LEARNING; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; SERINE; STRYCHNINE;

EID: 0030898951     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. ANTHONY, E. W. AND NEVINS, M. E.: Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test. Eur. J. Pharmacol. 250: 317-324, 1993.
2. ASCHER, P. AND NOWAK, L.: Electrophysiological studies of NMDA receptors. Trends Neurosci. 10: 284-287, 1987.
3. BALSTER, R. L., MANSBACH, R. S., SHELTON, K. L., NICHOLSON, K. L., GRECH, D. M., WILEY, J. L., Li, H. AND WEBER, E.: Behavioural pharmacology of two novel substituted quinozalinedione glutamate antagonists. Behav. Pharmacol. 6: 577-590, 1995.
4. BALSTER, R. L. AND WILLETTS, J.: Receptor mediation of the discriminative stimulus properties of phencyclidine and sigma-opioid agonists. In Transduction Mechanisms of Drug Stimuli, ed. by F. C. Colpaert and R. L. Balster, pp. 122-135, Springer-Verlag, Berlin, 1988.
5. BARON, S. P. AND WOODS, J. H.: Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine. Psychopharmacology 118: 42-51, 1995.
6. CARTER, A. J.: Glycine antagonists: Regulation of the NMDA receptor-channel complex by the strychnine-insensitive glycine site. Drugs Future 17: 595-613, 1992.
7. CONTRERAS, P.: D-Serine antagonized phencyclidine and MK-801-induced stereotyped behavior and ataxia. Neuropharmacology 29: 291-293, 1990.
8. CORBETT, R.: Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue. Pharmacol. Biochem. Behav. 51: 561-564, 1995.
9. CORBETT, R. AND DUNN, R. W.: Effects of 5,7 dichlorokynurenic acid on conflict, social interaction and plus maze behaviors. Neuropharmacology 32: 461-466, 1993.
10. DITZLER, K.: Efficacy and tolerability of memantine in patients with dementia syndrome. Arzneim. Forsch. Drug Res. 41: 773-780, 1991.
11. EVONIUK G. E., HERTZMAN R. P. AND SKOLNICK P.: A rapid method for evaluating the behavioral effects of phencyclidine-like dissociative anesthetics in mice. Psychopharmacology 105: 125-128, 1991.
12. FAIMAN, C. P., UIU, E., SKOLNICK, P. AND TRULLAS, R.: Differential effects of compounds that act at strychnine-insensitive glycine receptors in a punishment procedure. J. Pharmacol. Exp. Ther. 270: 528-533, 1994.
13. FINNEY, D. J.: Statistical Methods in Biological Assay, 2nd ed., Hafner, New York, 1964.
14. FRANCE, C. P., MOERSCHBAECHER, J. M. AND WOODS, J. H.: MK-801 and related compounds in monkeys: Discriminative stimulus effects and effects on a conditional discrimination. J. Pharmacol. Exp. Ther. 257: 727-734, 1991.
15. GETER-DOUGLASS, B. AND WITKIN, J. M.: Discriminative stimulus effects of low affinity noncompetitive NMDA antagonists. NIDA Research Monograph Problems of Drug Dependence, in press, 1996.
16. HARRIS, E. W.: Subtypes of glutamate receptors: Pharmacological classification. In CNS Neurotransmitters and Neuromodulators, vol. 1: Glutamate, ed. by T. W. Stone, pp. 95-125, CRC Press, Boca Raton, FL, 1995.
17. HOLTZMAN, S. G.: Discriminative stimulus effects of drugs: Relationship to potential for abuse. In Modern Methods in Pharmacology, Testing and Evaluation of Drugs of Abuse, vol. 6, pp. 193-210, Wiley-Liss Inc, New York, New York, 1990.
18. JACKSON A. AND SANGER D. J.: Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors? Psychopharmacology 96: 87-92, 1988.
19. JOHNSON, J. W. AND ASCHER, P.: Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature (Lond.) 325: 529-531, 1987.
20. JOHNSON, K. M. AND JONES, S. M.: Neuropharmacology of phencyclidine: Basic mechanisms and therapeutic potential. Annu. Rev Pharmacol. Toxicol. 30: 707-750, 1990.
21. KAMIEN, J. B., BICKEL, W. K., HUGHES, J. R., HIGGINS, S. T. AND SMITH, B.: Drug discrimination by humans compared to nonhumans: Current status and future directions. Psychopharmacology 111: 259-270, 1993.
22. KEMP, J. A. AND LEESON, P. D.: The glycine site on the NMDA receptor: five years on. Trends Pharmacol. Sci. 14: 20-25, 1993.
23. KLECKNER, N. W. AND DINGELDINE, R.:Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241: 444-449, 1988.
24. KLOOG, Y., HARING, R. AND SOKOLOVSKY, M.: Kinetic characterization of the phencylidine-N-methyl-D-aspartate receptor interaction: Evidence for a steric blockade of the channel. Biochemistry 27: 843-848, 1988.
25. KLOOG, Y., LAMDANI-ITKIN, H. AND SOKOLOVSKY, M.: The glycine site of the N-methyl-D-aspartate receptor channel: Differences between the binding of HA-966 and of 7-chlorokynurenic acid. J. Neurochem. 54: 1576-1583, 1990.
26. KOEK, W. AND COLPAERT F. C.: N-methyl-D-aspartate antagonism and phencyclidine like activity: Behavioral effects of glycine site ligands. In Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection? ed. by J.-M. Kamenka and E. F. Domino, pp. 655-671, NPP Books, Ann Arbor, MI, 1992.
27. KOEK, W., COLPAERT, F. C. AND VIGNON, J.: Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: Pharmacological and behavioral characterization of intermediate levels of drug lever selection. J. Pharmacol. Exp. Ther. 264: 746-756, 1993.
28. KOEK, W., WOODS, J. H. AND COLPAERT, F. C.: N-Methyl-D-aspartate antagonism and phencyclidine-like activity: A drug discrimination analysis. J. Pharmacol. Exp. Ther. 253: 1017-1024, 1990.
29. LEESON, P. D. AND IVERSEN, L. L.: The glycine site on the NMDA receptor: Structure-activity relationships and therapeutic potential. J. Med. Chem. 37: 4053-4067, 1994.
30. MILLER, R., L. A. GRONE, J., SKOLNICK, P. AND BOJE, K.: A high performance liquid chromatography assay for 1-Aminocyclopropanecarboxylic acid in plasma and brain tissue. J. Chromatogr. Biomed. Appl. 578: 103-108, 1992.
31. MORETON, J. E., ROBLES, L., WITKIN, J. M., SHARPE, L. G. AND TORTELLA, F. C.: Effects of D-serine on EEG, overt behavior and discriminative stimulus effects of PCP in rats. Soc. Neurosci. Abstr. 17: 1438, 1991.
32. MUIR, K. W. AND LEES, K. R.: Clinical experience with exciatatory amino acid antagonist drugs. Stroke 26: 503-513, 1995.
33. OLNEY, J.: Excitatory amino acids and neuropsychiatric disorders. Biol. Psychiatry 26: 505-525, 1989.
34. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, NY, 1982.
35. PETERSON, S. L. AND SCHWADE, N. D.: The anticonvulsant activity of D-cycloserine is specific for tonic convulsions. Epilepsy Res. 15: 141-148, 1993.
36. POTKIN, S. G., COSTA, J., ROY, S., SRAMEK, J., JIN, Y. AND GULASEKARMA, B.: Glycine in the treatment of schizophrenia: Theory and preliminary results. In Novel Antipsychotic Drugs, ed. by H. Y. Meltzer, pp. 179-108, Raven Press, Ltd., New York, 1992.
37. RABEY, J. M., NISSIPEANU, P. AND KORCZYN, A. D.: Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease. J. Neural Transm. 4: 277-282, 1992.
38. REID, A. A., MONN, J. A., JACOBSON, A. E., RICE, K. C. AND ROTHMANN, R. B.: Pseudoallosteric modulation by (+)-MK-801 of NMDA-coupled phencyclidine binding sites. Life Sci.-Pharmacol. Lett. 46: PL77-PL82, 1990.
39. SALT, T. E.: Modulation of NMDA receptor-mediated responses by glycine and D-serine in the rat thalamus in vivo. Brain Res. 481: 403-406, 1989.
40. SANGER, D. J., TERRY, P. AND KATZ, J. L.: Memantine has phencyclidine-like but not cocaine-like discriminative stimulus effects in rats. Behav. Pharmacol. 3: 265-268, 1992.
41. SANGER. D. J. AND ZIVKOVIC, B.: The discriminative stimulus effects of MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists. J. Psychopharmacol. 3: 198-204, 1989.
42. SCHUSTER, C. R. AND JOHANSON, C. E.: Relationship between the discriminative stimulus properties and subjective effects of drugs. In Transduction Mecahnisms of Drug Stimuli, ed. by F. C. Colpaert and R. L. Balster, pp. 161-175, Springer-Verlag, Berlin, 1988.
43. SINGH, L., DONALD, A. E., FOSTER, A. C., HUTSON, P. H., IVERSEN, L. L., IVERSEN, S. D., KEMP, J. A., LEESON, P. D., MARSHALL, G. R., OLES, R. J., PRIESTLEY, T., THORN, L., TRICKLEBANK, M. D., VASS, C. A. AND WILLIAMS, B. J.: Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate, but (-)-HA-966 is a potent γ-butyrolactone-like sedative. Proc. Natl. Acad. Sci. U.S.A. 87: 347-351, 1990a.
44. SINGH, L., MENZIES, R. AND TRICKLEBANK, M. D.: The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-D-aspartate receptor. Eur. J. Pharmacol. 186: 129-132, 1990b.
45. SKOLNICK, P., MARVIZÓN, J., JACKSON, B., MONN, J., RICE, K. AND LEWIN, A.: Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci. 45: 1647-1655, 1989.
46. SNEDECOR, G. W. AND COCHRAN, W. G.: Statistical Methods, 6th ed., pp. 135-171, Iowa State University Press, Ames, IA, 1967.
47. TANII, Y., NISHIKAWA, T., HASHIMOTO, A. AND TAKAHASHI, K.: Stereoselective inhibition by D- and L-alanine of phencyclidine-induced locomotor stimulation in the rat. Brain Res. 563: 261-284, 1991.
48. TANII, Y., NISHIKAWA, T., HASHIMOTO, A. AND TAKAHASHI, K.: Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia. J. Pharmacol. Exp. Ther. 269: 1040-1048, 1994.
49. THOMSON, A. M., WALKER, V. E. AND FLYNN, D. M.: Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices. Nature 338: 422-424, 1989.
50. TORU, M., KURUMAJI, A. AND ISHIMARU, M.: Excitatory amino acids: Implications for psychiatric disorders research. Life Sci. 55: 1683-1699, 1994.
51. TOTH, E. AND LAJTHA, A.: Antagonism of phencyclidine-induced hyperactivity by glycine in mice. Neurochem. Res. 11: 393-400, 1986.
52. TRICKLEBANK, M. D., SINGHLOLE, R. J., WONG, E. H. F. AND IVERSEN, S. D.: A role for the N-methyl-D-aspartic acid receptor in the discriminative stimulus properties of phencyclidine. Eur. J. Pharmacol. 141: 497-501, 1987.
53. TRULLAS, R. AND SKOLNICK P.: Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol. 185: 1-10, 1990.
54. TRULLAS, R., FOLIO, T., YOUNG, A., MILLER, R., BOJE, K. AND SKOLNICK P.: 1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions Eur. J. Pharmacol. 203: 379-385, 1991.
55. WACHTEL, H. AND TURSKI, L.: Glutamate: A new target for schizophrenia? Trends Pharmacol. Sci. 11: 219-220, 1990.
56. WILLETTS, J., BALSTER, R. L. AND LEANDER, J. D.: The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci. 11: 423-428, 1990.
57. WILLETTS, J., CLISSOLD, D. B., HARTMAN, T. L., BRANDSGAARD, R. R., HAMILTON, G. S. AND FERKANY, J. W.: Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist. J. Pharmacol. Exp. Ther. 265: 1055-1062, 1993.
58. WITKIN, J. M.: Differential blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists. Life Sci. 53: PL405-PL410, 1993.
59. WITKIN, J. M.: Role of N-methyl-D-aspartate receptors in behavior and behavioral effects of drugs. CNS Neurotransmitters and Neuromodulators, vol. 1: Glutamate, ed. by T. W. Stone, pp. 323-350, CRC Press, Boca Raton, FL, 1995.
60. WITKIN, J. M., BRAVE, S., FRENCH, D. AND GETER-DOUGLASS, B.: Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor. J. Pharmacol. Exp. Ther. 275: 1267-1273, 1995.
61. WITKIN, J. M. AND STEELE, T. D.: Effects of strychnine-insensitive glycine receptor ligands on discriminative stimulus effects of N-methyl-D-aspartate (NMDA) channel antagonists. Soc. Neurosci. Abstr. 18: 447, 1992.
62. WITKIN, J. M. AND TORTELLA, F. C.: Modulators of N-methyl-D-aspartate protect against diazepam- or phenobarbital-resistant cocaine convulsions. Life Sci.-Pharmacol. Lett. 48: PL51-PL56, 1991.
63. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptro channel complex in rat brain membranes. J. Neurochem. 50: 274-281, 1988.